Chemoinformaics analysis of 2-[(E)-PENT-1-ENYL]FURAN
| Molecular Weight | 136.194 | nRot | 3 |
| Heavy Atom Molecular Weight | 124.098 | nRig | 8 |
| Exact Molecular Weight | 136.089 | nRing | 1 |
| Solubility: LogS | -6.993 | nHRing | 1 |
| Solubility: LogP | 7.592 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 22 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 5 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 5 |
| nHA | 1 | APOL | 23.8335 |
| nHD | 0 | BPOL | 13.7745 |
| QED | 0.265 |
| Synth | 1.949 |
| Natural Product Likeliness | -0.081 |
| NR-PPAR-gamma | 0.024 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.947 |
| Pgp-sub | 0.001 |
| HIA | 0.001 |
| CACO-2 | -4.799 |
| MDCK | 0.0000185 |
| BBB | 0.02 |
| PPB | 0.982788 |
| VDSS | 1.853 |
| FU | 0.0142626 |
| CYP1A2-inh | 0.299 |
| CYP1A2-sub | 0.188 |
| CYP2c19-inh | 0.637 |
| CYP2c19-sub | 0.052 |
| CYP2c9-inh | 0.197 |
| CYP2c9-sub | 0.789 |
| CYP2d6-inh | 0.527 |
| CYP2d6-sub | 0.053 |
| CYP3a4-inh | 0.449 |
| CYP3a4-sub | 0.059 |
| CL | 8.473 |
| T12 | 0.065 |
| hERG | 0.247 |
| Ames | 0.004 |
| ROA | 0.002 |
| SkinSen | 0.944 |
| Carcinogencity | 0.255 |
| EI | 0.987 |
| Respiratory | 0.05 |
| NR-Aromatase | 0.17 |
| Antiviral | No |
| Prediction | 0.940373 |